IOVA Stock Analysis: Buy, Sell, or Hold?
IOVA - Iovance Biotherapeutics, Inc. Common Stock
$3.45
-0.06 (-1.71%)
▼
5d:
-8.0%
30d:
-7.88%
90d:
+24.55%
HOLD
LOW Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
IOVA is down 4.9% this week, but smart money is accumulating calls. Top strike: $5 2026-06-18 with 4,951 OI. Call ratio: 81% View Scanner →
Strength: 5.5/10
Get Alerted When IOVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IOVA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IOVA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IOVA is currently trading at $3.45, which is considered slightly low relative to its 30-day fair value range of $3.39 to $4.53.
Technical Outlook: Technically, IOVA is in a strong uptrend. Immediate support is located at $3.26, while resistance sits at $3.97.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+160.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IOVA is in a strong uptrend. Immediate support is located at $3.26, while resistance sits at $3.97.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+160.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$3.39 -
$4.53
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 160.9% below Wall St target ($9.00)
- CAUTION: Recommendation downgraded due to -8.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$3.39 -
$4.53
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.26
Resistance Level
$3.97
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.32
Wall Street Target
$9.00
(+160.9%)
Revenue Growth (YoY)
17.7%
Profit Margin
-148.4%
Share & Embed Analysis
Last updated: April 02, 2026 7:56 AM ET
Data refreshes hourly during market hours. Next update: 8:56 AM
Data refreshes hourly during market hours. Next update: 8:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IOVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 63 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 63 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 57 HOLD |
